Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease & Stroke
Lp-PLA2 activity strongly associated with coronary heart disease, stroke
September 27th, 2004
New results from the Rotterdam Study presented at the ESC Congress 2004 validate the growing body of evidence demonstrating a critical link between an enzyme implicated in atherosclerosis - lipoproteinassociated phospholipase A2 (Lp-PLA2) - and both heart disease and stroke. The results, presented by Albert Hofman, MD, PhD, Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, showed that Lp-PLA2 activity is strongly associated with coronary heart disease and stroke in the general population, regardless of total cholesterol or other markers of inflammation. The Rotterdam Study is a population-based, follow-up study of 7,983...
Source: Obesity & Diabetes Week (2004-09-27)
|
